Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (441-450 of 548) with videos related to

Pageof 55
Sort By:
The New England Journal of Medicine|December 21, 2012
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritisFabrizio De Benedetti, Hermine I Brunner, Nicolino Ruperto, et al.
Rheumatology (Oxford, England)|January 29, 2019
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositisSilvia Rosina, Alessandro Consolaro, Pieter van Dijkhuizen, et al.
Arthritis Care & Research|December 16, 2017
Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine CareGiulia Camilla Varnier, Silvia Rosina, Cristina Ferrari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2020
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III TrialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.
Arthritis Care & Research|August 18, 2019
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim ResultsHermine I Brunner, Kabita Nanda, Mary Toth, et al.
Annals of the Rheumatic Diseases|May 23, 2013
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER studyGerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Urology Focus|February 6, 2023
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyFabio Zattoni, Giancarlo Marra, Alberto Martini, et al.
Arthritis and Rheumatism|February 3, 2007
Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort studySheila Oliveira, Angelo Ravelli, Angela Pistorio, et al.
Arthritis Care & Research|August 27, 2016
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic ArthritisPaula Frid, Ellen Nordal, Francesca Bovis, et al.
Pageof 55

Showing results (441-450 of 548) with videos related to

Sort By:
Pageof 55
The New England Journal of Medicine|December 21, 2012
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritisFabrizio De Benedetti, Hermine I Brunner, Nicolino Ruperto, et al.
Rheumatology (Oxford, England)|January 29, 2019
Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositisSilvia Rosina, Alessandro Consolaro, Pieter van Dijkhuizen, et al.
Arthritis Care & Research|December 16, 2017
Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine CareGiulia Camilla Varnier, Silvia Rosina, Cristina Ferrari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2020
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III TrialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.
Arthritis Care & Research|August 18, 2019
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim ResultsHermine I Brunner, Kabita Nanda, Mary Toth, et al.
Annals of the Rheumatic Diseases|May 23, 2013
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER studyGerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Urology Focus|February 6, 2023
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyFabio Zattoni, Giancarlo Marra, Alberto Martini, et al.
Arthritis and Rheumatism|February 3, 2007
Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort studySheila Oliveira, Angelo Ravelli, Angela Pistorio, et al.
Arthritis Care & Research|August 27, 2016
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic ArthritisPaula Frid, Ellen Nordal, Francesca Bovis, et al.
Pageof 55